Etiqueta: stem cells
-
Adipose Tissue-Derived Stem Cells Inhibit Neointimal Formation in a Paracrine Fashion in Rat Femoral Artery
In the study, fat mesenchymal stem cells were isolated from rats and tested for ability to promote healing of the endothelium, which is the lining of the blood vessels.
-
Stem Cells May Improve Heart Bypass Results
The study demonstrated efficacy in the treated patients based on increase cardiac muscle contraction ability as compared to patients that had bypass surgery but did not receive stem cells.
-
Liver Cells Generated from Skin Cells
Mice that received the artificially generated liver cells, but not control mice, had a recovery in production of liver enzymes.
-
Virus Engineered Stem Cells Protect Against Lung Injury
Mice were treated with mouse mesenchymal stem cells and mouse hematopoietic stem cells that were genetically engineered using lentiviruses.
-
Matrix Modulation of Compensatory Lung Regrownth and Progenitor Cell Proliferation in Mice
In the last 2 decades studies have been showing that organs such as the heart, brain and kidney have "endogenous stem cells" that are capable of creating a certain, albeit small, degree of regeneration after injury.
-
Beauty Brand Publishes Study on Stem Cell Wonder Cream
The French beauty brand Lancôme released results on its product, "Absolue Precious Cells", a face cream being toted as having antiaging properties based on stem cell content.
-
Use of Frozen Stem Cells Successful in Heart Failure
In a recent paper the use of mesenchymal stem cells was evaluated after the cells have been stored frozen.
-
Cord Blood Cells Make New Blood Vessels
A paper published today from the Mary Laughlin’s group describes the use of cord blood cells in creation of new blood vessels.
-
Recipient Response to Stem Cells Contributes to Brain Repair in Rats
Do the growth factors made by stem cells in response to injury are actually made by the stem cells, or whether the stem cells are «instructing» the injured tissue to make growth factors.
-
NOXXON Announces Initiation of First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing Spiegelmer® NOX-A12
Today NOXXON announced that is has successfully administered its NOX-A12 aptamer-based mobilizer to healthy volunteers as part of a Phase I clinical trial.